| 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus M Aringer, K Costenbader, D Daikh, R Brinks, M Mosca, ... Arthritis & rheumatology 71 (9), 1400-1412, 2019 | 2630 | 2019 |
| Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2 … RF van Vollenhoven, BH Hahn, GC Tsokos, CL Wagner, P Lipsky, ... The Lancet 392 (10155), 1330-1339, 2018 | 302 | 2018 |
| Risk of cardiovascular morbidity in patients with psoriatic arthritis: a meta‐analysis of observational studies ARI Polachek, Z Touma, M Anderson, L Eder Arthritis care & research 69 (1), 67-74, 2017 | 219 | 2017 |
| Mycophenolate mofetil for induction treatment of lupus nephritis: a systematic review and metaanalysis Z Touma, DD Gladman, MB Urowitz, J Beyene, EM Uleryk, PS Shah The Journal of rheumatology 38 (1), 69-78, 2011 | 150 | 2011 |
| Apoptotic cell–induced AhR activity is required for immunological tolerance and suppression of systemic lupus erythematosus in mice and humans R Shinde, K Hezaveh, MJ Halaby, A Kloetgen, A Chakravarthy, ... Nature immunology 19 (6), 571-582, 2018 | 145 | 2018 |
| How do patients with newly diagnosed systemic lupus erythematosus present? A multicenter cohort of early systemic lupus erythematosus to inform the development of new … M Mosca, KH Costenbader, SR Johnson, V Lorenzoni, GD Sebastiani, ... Arthritis & Rheumatology 71 (1), 91-98, 2019 | 129 | 2019 |
| Current and future therapies for SLE: obstacles and recommendations for the development of novel treatments Z Touma, DD Gladman Lupus science & medicine 4 (1), e000239, 2017 | 119 | 2017 |
| Time to recovery from proteinuria in patients with lupus nephritis receiving standard treatment Z Touma, MB Urowitz, D Ibañez, DD Gladman The Journal of rheumatology 41 (4), 688-697, 2014 | 105 | 2014 |
| SLEDAI-2K 10 days versus SLEDAI-2K 30 days in a longitudinal evaluation Z Touma, MB Urowitz, D Ibanez, DD Gladman Lupus 20 (1), 67-70, 2011 | 102 | 2011 |
| What is the prevalence of cognitive impairment in lupus and which instruments are used to measure it? A systematic review and meta-analysis H Al Rayes, C Tani, A Kwan, S Marzouk, K Colosimo, J Medina-Rosas, ... Seminars in arthritis and rheumatism 48 (2), 240-255, 2018 | 95 | 2018 |
| SLEDAI-2K for a 30-day window Z Touma, MB Urowitz, DD Gladman Lupus 19 (1), 49-51, 2010 | 93 | 2010 |
| Cardiac sarcoidosis responding to monotherapy with infliximab I Uthman, Z Touma, M Khoury Clinical rheumatology 26, 2001-2003, 2007 | 92 | 2007 |
| Prevalence and metric of depression and anxiety in systemic lupus erythematosus: a systematic review and meta-analysis AT Moustafa, M Moazzami, L Engel, E Bangert, M Hassanein, S Marzouk, ... Seminars in arthritis and rheumatism 50 (1), 84-94, 2020 | 89 | 2020 |
| Is there an advantage over SF-36 with a quality of life measure that is specific to systemic lupus erythematosus? Z Touma, DD Gladman, D Ibañez, MB Urowitz The Journal of rheumatology 38 (9), 1898-1905, 2011 | 88 | 2011 |
| Minimal Clinically Important Difference: A Review of Outcome Measure Score Interpretation L Engel, DE Beaton, Z Touma Rheum Dis Clin North Am 44 (2), 177-188, 2018 | 87 | 2018 |
| Development and initial validation of the systemic lupus erythematosus disease activity index 2000 responder index 50 Z Touma, DD Gladman, D Ibañez, MB Urowitz The Journal of rheumatology 38 (2), 275-284, 2011 | 86 | 2011 |
| Disease course patterns in systemic lupus erythematosus K Tselios, DD Gladman, Z Touma, J Su, N Anderson, MB Urowitz Lupus 28 (1), 114-122, 2019 | 79 | 2019 |
| TNF polymorphisms in patients with Behcet disease: a meta-analysis Z Touma, C Farra, A Hamdan, W Shamseddeen, I Uthman, H Hourani, ... Archives of medical research 41 (2), 142-146, 2010 | 79 | 2010 |
| Belimumab use, clinical outcomes and glucocorticoid reduction in patients with systemic lupus erythematosus receiving belimumab in clinical practice settings: results from the … Z Touma, A Sayani, CA Pineau, I Fortin, M Matsos, GA Ecker, A Chow, ... Rheumatology international 37, 865-873, 2017 | 78 | 2017 |
| Electrocardiogram abnormalities related to anti-malarials in systemic lupus erythematosus TK McGhie, P Harvey, J Su, N Anderson, G Tomlinson, Z Touma Clin Exp Rheumatol 36 (4), 545-551, 2018 | 75 | 2018 |
